Efficacy News and Research

RSS

Scientists develop new technology to better study liver transplantation in pre-clinical setting

A team of scientists, physicians, and engineers from the Center for Engineering in Medicine and the Transplant Center of the Massachusetts General Hospital at the Harvard Medical School in Boston, MA reported the development of a new technology that enables researchers to better study liver transplantation in a pre-clinical setting.

29 Nov 2017

Immediate ART treatment following HIV diagnosis increases retention in care, study suggests

Starting antiretroviral therapy immediately following an HIV diagnosis dramatically improves retention in clinical HIV care, according to a study led by a Boston University School of Public Health researcher.

29 Nov 2017

Researchers develop novel method to improve delivery of chemotherapy nanodrugs

Carnegie Mellon University researchers have developed a new method for delivering chemotherapy nanodrugs that increases the drugs' bioavailability and reduces side-effects.

29 Nov 2017

Kessler Foundation researcher wins NIDILRR subaward to improve outcomes in patients with SCI

Amanda Botticello, PhD, MPH, received a $605,000 subaward from the National Institute on Disability Independent Living and Rehabilitation Research to study a cognitive-behavioral intervention in the outpatient population with spinal cord injury (SCI).

28 Nov 2017

Researchers reveal impact of RNA-binding protein on memory formation process

Learning requires the chemical adaptation of individual synapses. Researchers have now revealed the impact of an RNA-binding protein that is intimately involved in this process on learning and memory formation and learning processes.

28 Nov 2017

New cancer drug begins clinical trial in human patients with rare brain tumor

A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma, a rare malignant brain tumor, and glioblastoma multiforme, an aggressive late-stage cancer of the brain.

28 Nov 2017

Direct switch of COPD patients from Seretide to Novartis' Ultibro Breezhaler improves lung function

Novartis today announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease (COPD) patients from Seretide (salmeterol/fluticasone) 50/500 mcg to Ultibro Breezhaler (indacaterol/glycopyrronium) 110/50 mcg.

27 Nov 2017

New approach can track how superbugs travel among and within health care facilities

Killer bacteria – ones that have out-evolved our best antibiotics -- may not go away anytime soon. But a new approach to tracking their spread could eventually give us a fighting chance to keep their death toll down.

23 Nov 2017

Researchers question exclusion of people with prior cancer history from clinical trials

A quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer – often preventing them from participating in clinical trials, researchers from UT Southwestern's Simmons Cancer Center have found.

22 Nov 2017

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

When choosing their preferred treatment, people with chronic lymphocytic leukemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious adverse events according to a study published online in Blood Advances, a Journal of the American Society of Hematology.

22 Nov 2017

Controlling organ functions with your cell phone may be possible in future

Think about this. You have diabetes, are trying to control your insulin levels and instead of taking a pill or giving yourself an injection, you click an app on your phone that tells your pancreas to bring blood sugar levels back to normal.

22 Nov 2017

Study: Non-vitamin K antagonist oral anticoagulants linked to reduced kidney risks

Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.

20 Nov 2017

Research finds mental and emotional health apps as effective self-help tools

When it comes to strengthening your mental or emotional health, would you trust an app? A trio of Brigham Young University health science researchers has published new research that says the answer is yes.

20 Nov 2017

Enterovirus vaccine protects against virus-induced diabetes in mouse model

Scientists at the University of Tampere and the Karolinska Institutet have demonstrated that an enterovirus vaccine can protect against virus-induced diabetes in a mouse model for Type 1 diabetes.

20 Nov 2017

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

A randomized trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic colorectal cancer, researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

ASU professor reveals more about craniofacial conditions before release of ‘Wonder’

The new film "Wonder" tells the story of a young boy who overcomes the challenges of living with the facial structural abnormality known as Treacher Collins Syndrome.

17 Nov 2017

Research suggests new ways to mitigate impact of mistreatment at early age

Everyone has challenges of one kind or another. But research shows that mistreatment at an early age can have long-lasting and life-altering repercussions that could be passed to future generations.

17 Nov 2017

FDA approves new drug to treat bleeding in hemophilia A patients

The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII) inhibitors.

17 Nov 2017

Stem cell treatment allows paraplegic rats to walk and regain sensory perception

Engineered tissue containing human stem cells has allowed paraplegic rats to walk independently and regain sensory perception.

16 Nov 2017

Efficacy News and Research

Scientists develop new technology to better study liver transplantation in pre-clinical setting

Immediate ART treatment following HIV diagnosis increases retention in care, study suggests

Researchers develop novel method to improve delivery of chemotherapy nanodrugs

Kessler Foundation researcher wins NIDILRR subaward to improve outcomes in patients with SCI

Researchers reveal impact of RNA-binding protein on memory formation process

New cancer drug begins clinical trial in human patients with rare brain tumor

Direct switch of COPD patients from Seretide to Novartis' Ultibro Breezhaler improves lung function

New approach can track how superbugs travel among and within health care facilities

Researchers question exclusion of people with prior cancer history from clinical trials

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

Controlling organ functions with your cell phone may be possible in future

Study: Non-vitamin K antagonist oral anticoagulants linked to reduced kidney risks

Research finds mental and emotional health apps as effective self-help tools

Enterovirus vaccine protects against virus-induced diabetes in mouse model

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

ASU professor reveals more about craniofacial conditions before release of ‘Wonder’

Research suggests new ways to mitigate impact of mistreatment at early age

FDA approves new drug to treat bleeding in hemophilia A patients

Stem cell treatment allows paraplegic rats to walk and regain sensory perception

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News